ENPRO INC (NPO)
Sector: Industrials
2026 Annual Meeting Analysis
ENPRO INC · Meeting: April 29, 2026
Directors FOR
8
Directors AGAINST
0
Say on Pay
FOR
Auditor
FOR
Director Elections
Election of Directors
CEO and director since 2021; NPO's 3-year price return of 173.1% outperforms the company-disclosed peer group median by +67.9 percentage points, well above the 50pp threshold required to trigger a vote against for strong-positive TSR periods, and no overboarding, attendance, or independence concerns apply.
Director since 2022 (within 24 months of the proxy date, triggering the new-director exemption from the TSR test); brings deep semiconductor industry expertise directly relevant to Enpro's Advanced Surface Technologies segment, and no other policy flags apply.
Director since 2024 and therefore exempt from the TSR trigger as a director joining within the past 24 months; serves as a designated audit committee financial expert with CPA credentials and extensive CFO experience, and no other policy flags apply.
Director since 2012 with long tenure; NPO's 3-year return of 173.1% outperforms the peer group median by +67.9pp, comfortably below the 50pp underperformance threshold needed to trigger a vote against, and no overboarding, attendance, or independence concerns are identified.
Director since 2014; strong TSR performance versus peers means the TSR trigger does not apply, and his operational transformation expertise at McKinsey is directly relevant to Enpro's industrial technology businesses with no other policy flags noted.
Director since 2018; NPO's outperformance versus peers clears the TSR threshold with no trigger, and she holds two current public company board seats (NewAmsterdam Pharma and Tyra Biosciences), well below the four-seat overboarding limit, with no other policy flags.
Director since 2015 and audit committee chair with prior CFO experience qualifying him as an audit committee financial expert; NPO's strong peer-relative TSR does not trigger a vote against, and his two current outside board seats (Ingersoll Rand and O-I Glass) are within policy limits.
Director since 2021; the TSR trigger does not apply given NPO's strong performance versus peers, and she holds two current public company board seats (Nurix Therapeutics and Toll Brothers), within policy limits, with relevant legal and governance expertise.
All eight director nominees receive a FOR vote. NPO's 3-year price return of 173.1% outperforms the company-disclosed compensation peer group median by +67.9 percentage points, which is above the applicable strong-positive-TSR threshold of +50pp needed to trigger votes against — meaning the TSR trigger does not fire for any director with sufficient tenure. Directors Abbey and Aden joined within the past 24 months and are exempt from the TSR test regardless. No overboarding, attendance failures, independence conflicts, or familial relationship concerns are identified for any nominee.
Say on Pay
✓ FORCEO
Eric A. Vaillancourt
Total Comp
$7,457,747
Prior Support
97.0%%
CEO total compensation of $7.46 million is reasonable for a $5.5 billion market cap industrial company — base salary of approximately $935,000 sits within expected ranges for this role and sector, and the pay mix is strongly weighted toward variable compensation (roughly 87% of total pay is variable, well above the 60% policy floor). The annual bonus paid out at 130.5% of target based on above-target adjusted EBITDA and near-maximum Cash Flow ROIC performance, and the 2023-2025 performance share awards vested at 149% of target based on NPO ranking at the 62nd percentile of the S&P SmallCap 600 Capital Goods Index — both outcomes are credibly tied to measured results rather than guaranteed. The pay-for-performance alignment is strong: NPO's 3-year total shareholder return of 173.1% significantly outperforms the peer group median of 105.2%, confirming that above-target incentive payouts were earned in a period when shareholders also did well; the prior say-on-pay vote of 97% approval signals broad shareholder satisfaction, and the program includes meaningful clawback policies and stock ownership requirements.
Auditor Ratification
✓ FORAuditor
PricewaterhouseCoopers LLP
Tenure
N/A
Audit Fees
N/A
Non-Audit Fees
N/A
PricewaterhouseCoopers LLP is a Big 4 firm appropriate for a $5.5 billion market cap industrial company. Auditor tenure is not disclosed in the filing text provided, so the tenure trigger cannot fire per policy — the absence of tenure disclosure is noted as a minor negative factor but does not change the vote. No fee table data was included in the filing excerpt provided, so the non-audit fee ratio trigger cannot be evaluated; in the absence of confirmed data triggering a No, the default FOR applies. No material restatements are disclosed.
Overall Assessment
Enpro's 2026 annual meeting ballot contains three standard proposals — director elections, say-on-pay, and auditor ratification — all of which receive a FOR vote under this policy. The company's strong stock performance (173.1% over three years, outperforming its disclosed peer group by nearly 68 percentage points) eliminates TSR-based concerns for directors, the executive compensation program is genuinely performance-linked with 97% prior shareholder approval, and PricewaterhouseCoopers is an appropriate Big 4 auditor for a company of Enpro's size; no stockholder proposals appear on this ballot.
Compensation Peer Group
18 companies disclosed in 2026 proxy filing